These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4119906)

  • 21. Comparison of triazines as inhibitors of L1210 dihydrofolate reductase and of L1210 cells sensitive and resistant to methotrexate.
    Selassie CD; Strong CD; Hansch C; Delcamp TJ; Freisheim JH; Khwaja TA
    Cancer Res; 1986 Feb; 46(2):744-56. PubMed ID: 3940640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolongation of the lag period preceding the enhancement of thymidine and thymidylate kinase activity in regenerating rat liver by 5-azacytidine.
    Cihák A; Veselý J
    Biochem Pharmacol; 1972 Dec; 21(24):3257-65. PubMed ID: 4119298
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin.
    Plagemann PG; Behrens M; Abraham D
    Cancer Res; 1978 Aug; 38(8):2458-66. PubMed ID: 78761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced uridine kinase in rat liver following 5-azacytidine administration. In vivo characterization and properties of partially purified enzyme.
    Cihák A; Veselý J
    J Biol Chem; 1973 Feb; 248(4):1307-13. PubMed ID: 4119815
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and antitumor activity of dihydro-5-azacytidine, a hydrolytically stable analogue of 5-azacytidine.
    Beisler JA; Abbasi MM; Kelley JA; Driscoll JS
    J Med Chem; 1977 Jun; 20(6):806-12. PubMed ID: 69026
    [No Abstract]   [Full Text] [Related]  

  • 26. Antileukemic activity of streptozotocin (NSC-85998) and its analogs.
    Bhuyan BK; Fraser TJ; Buskirk HH; Neil GL
    Cancer Chemother Rep; 1972 Dec; 56(6):709-20. PubMed ID: 4267348
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanism of resistance to 5-azacytidine in Bacillus subtilis. I. Isolation and some properties of mutants resistant to 5-azacytidine and 5-aza-2'-deoxycytidine.
    Fucík V; Zadrazil S; Jurovcík M; Sormová Z
    Folia Microbiol (Praha); 1972; 17(6):517-21. PubMed ID: 4118611
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of the alpha-D-anomer of 5-aza-2'-deoxycytidine on L1210 mouse leukemic cells in vitro and in vivo.
    Veselý J; Pískala A
    Cancer Res; 1984 Nov; 44(11):5165-8. PubMed ID: 6207913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF; Muggia FM; Johnson RK
    Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract]   [Full Text] [Related]  

  • 31. Dihydro-5-azacytidine hydrochloride, a biologically active and chemically stable analog of 5-azacytidine.
    Beisler JA; Abbasi MM; Driscoll JS
    Cancer Treat Rep; 1976 Nov; 60(11):1671-4. PubMed ID: 66095
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative biological and biochemical effects of nogalamycin and its analogs on L1210 leukemia.
    Li LH; Kuentzel SL; Murch LL; Pschigoda LM; Krueger WC
    Cancer Res; 1979 Dec; 39(12):4816-22. PubMed ID: 498110
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210.
    Young RC; DeVita VT
    Cancer Res; 1970 Jun; 30(6):1789-94. PubMed ID: 5457940
    [No Abstract]   [Full Text] [Related]  

  • 34. Kinetic evaluation of the effect of hydroxyurea on viability of replicating cultured leukemia L1210 cells.
    Wilkoff LJ; Lloyd HH; Dulmadge EA; Dixon GJ
    J Natl Cancer Inst; 1970 Jan; 44(1):201-9. PubMed ID: 11515031
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of different factors on liver thymidine monophosphate kinase in vivo and the synthesis of thymidine 5'-triphosphate in vitro.
    Greger J; Filippovich IV; Veselý J; Cihák A
    Acta Biochim Pol; 1972; 19(1):3-10. PubMed ID: 4113873
    [No Abstract]   [Full Text] [Related]  

  • 36. Pycnotic degeneration of ventricular cells in embryonic brain following transplacental exposure to 5-azacytidine.
    Seifertová M; Vesselý J; Cihák A; Sorm F
    Experientia; 1972 Jul; 28(7):841-2. PubMed ID: 4121448
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cells.
    Esnault C; Roques BP; Jacquemin-Sablon A; Le Pecq JB
    Cancer Res; 1984 Oct; 44(10):4355-60. PubMed ID: 6467197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth rate and cell kill.
    Hryniuk WM; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():330-42. PubMed ID: 5289425
    [No Abstract]   [Full Text] [Related]  

  • 39. 5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia.
    Von Hoff DD; Slavik M; Muggia FM
    Ann Intern Med; 1976 Aug; 85(2):237-45. PubMed ID: 60073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dose and duration of exposure on 5-aza-2'-deoxycytidine cytotoxicity for L1210 leukemia in vitro.
    Covey JM; Zaharko DS
    Cancer Treat Rep; 1984 Dec; 68(12):1475-81. PubMed ID: 6210141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.